Abstract LB278: IL-12 immunotherapy prevents hepatocellular carcinoma in a murine NAFLD induced cirrhosis model

白细胞介素12 肝细胞癌 肝硬化 免疫疗法 医学 CD8型 癌症研究 免疫学 穿孔素 免疫系统 内科学 生物 细胞毒性T细胞 生物化学 体外
作者
Mozhdeh Sojoodi,Stephen C. Barrett,Derek J. Erstad,Veronica Clavijo Jordan,Eric M. Gale,Shadi Salloum,Yongtao Wang,Michael Lanuti,Lawrence Zukerberg,Peter Caravan,Georg M. Lauer,Kenneth K. Tanabe
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (8_Supplement): LB278-LB278
标识
DOI:10.1158/1538-7445.am2023-lb278
摘要

Abstract Introduction: Interleukin 12 (IL-12) is an important bridge between the innate and adaptive immune systems. It is mainly produced by macrophages and can bind to its receptor (IL12R) on T cells. It affects several aspects of T cell activation, including IFN-γ and perforin production. Tumor-infiltrating CD8+ T cells perform important anti-tumoral actions, which need to be overcome to allow cancer cell growth. This work studied IL-12 administration as an HCC preventive strategy in cirrhotic mice. We investigated whether IL-12 can boost the recruitment of macrophages to the liver, increase their antigen-presenting ability, and activate cytolytic T cells to inhibit HCC development in cirrhotic livers. Method: 8 weeks old mice were fed a choline-deficient High fat diet (CDAHFD) for 16 weeks to create NAFLD-induced HCC. A subset of CDAHFD mice was injected intravenously with IL-12 (0.5mg/gr) weekly from 12 to 16 weeks. Mice were euthanized after 16 weeks, and liver and serum were collected for further analysis. Results: After tissue collection, we observed that 50% of untreated animals developed HCC lesions, while IL-12-treated mice did not have any HCC. After treatment with IL12, qPCR and western blot on total liver tissue showed up-regulation in the IL12 receptor and activation of the IL-12 pathway, evidenced by the increase in Stat4 expression and phosphorylation. Additionally, we detected an increase in IFN-γ expression by qPCR in IL-12-treated mice. Histological analysis showed a significant decrease in fat and collagen deposition in IL-12-treated livers compared to untreated livers. IL-12-treated mice had lower serum aminotransferase enzymes (AST & ALT), indicating improved liver function. Immunostaining and flow cytometry of F4/80 (macrophage marker) showed an increase in the number of macrophages in the livers treated with IL-12. Flow cytometry data showed that the majority of macrophages present in the IL-12 livers were CCR2+, a marker for recruited macrophages. Notably, IL-12-treated macrophages expressed more MHCII (antigen presentation marker) and less B7H4 (inhibitory marker). In addition, we observed a significant increase in the number of cytolytic T cells (CD8+) in the IL-12 treated livers, which had higher expression of the T cell activation marker (CD25) and elevated levels of perforin and IFN-γ that are nessacery for their cytotoxic activity. Conclusion: There is a lack of substantial evidence to describe the underlying mechanisms supporting the idea of cirrhosis regression and HCC prevention. Our study shows that the exogenous administration of IL-12 causes an increase in migrating profibrolysis macrophages to the liver and elevates cytolytic T-cell activity. IL-12 immunotherapy can trigger cirrhosis regression and prevent HCC development. Citation Format: Mozhdeh Sojoodi, Stephen C. Barrett, Derek J. Erstad, Veronica Clavijo Jordan, Eric M. Gale, Shadi Salloum, Yongtao Wang, Michael Lanuti, Lawrence Zukerberg, Peter Caravan, Georg M. Lauer, Kenneth K. Tanabe. IL-12 immunotherapy prevents hepatocellular carcinoma in a murine NAFLD induced cirrhosis model [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 2 (Clinical Trials and Late-Breaking Research); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(8_Suppl):Abstract nr LB278.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
刚刚
hhcosy完成签到,获得积分10
2秒前
李狗完成签到,获得积分10
2秒前
自由如风完成签到 ,获得积分10
2秒前
六个核桃手拉手完成签到 ,获得积分10
2秒前
3秒前
笑点低书文完成签到,获得积分10
3秒前
银杏完成签到,获得积分10
3秒前
小黄鱼完成签到,获得积分10
4秒前
高高小兔子完成签到 ,获得积分10
4秒前
LIU发布了新的文献求助10
4秒前
5秒前
5秒前
畅快山兰完成签到 ,获得积分10
5秒前
JIA完成签到 ,获得积分10
5秒前
洋地黄完成签到,获得积分10
6秒前
育三杯清栀完成签到 ,获得积分10
6秒前
吕布完成签到,获得积分10
7秒前
Waaly完成签到,获得积分10
7秒前
7秒前
zorro3574发布了新的文献求助30
7秒前
7秒前
共享精神应助犹豫代曼采纳,获得10
7秒前
李狗发布了新的文献求助10
8秒前
程程完成签到,获得积分10
8秒前
monkey完成签到,获得积分10
9秒前
qilavender发布了新的文献求助30
9秒前
Aloha完成签到 ,获得积分10
9秒前
wzh19940205完成签到,获得积分10
9秒前
9秒前
量子星尘发布了新的文献求助10
10秒前
噜噜晓完成签到 ,获得积分10
10秒前
zzzs完成签到,获得积分10
10秒前
慢慢完成签到,获得积分10
10秒前
幽默的谷梦完成签到,获得积分10
11秒前
李大龙发布了新的文献求助10
13秒前
14秒前
小黑鲨完成签到,获得积分10
15秒前
赫青亦完成签到 ,获得积分10
15秒前
胖达完成签到,获得积分10
16秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
Statistical Methods for the Social Sciences, Global Edition, 6th edition 600
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
ALUMINUM STANDARDS AND DATA 500
Walter Gilbert: Selected Works 500
岡本唐貴自伝的回想画集 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3666586
求助须知:如何正确求助?哪些是违规求助? 3225604
关于积分的说明 9763904
捐赠科研通 2935434
什么是DOI,文献DOI怎么找? 1607692
邀请新用户注册赠送积分活动 759302
科研通“疑难数据库(出版商)”最低求助积分说明 735250